Niagen Bioscience Inc
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $250.8M
- Price
- $3.17
- % Change (Daily % change from the live per-ticker quote feed.)
- +3.59%
- Volume
- 806.6K
About
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Quick stats
Shares outstanding79.1M
Computed float51.9M
Float / shares65.6%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001386570
AI Summary
AI-generated1/50
minorneutraloperations update
Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
Niagen Bioscience announced that CFO Ozan Pamir will present at the 17th Annual Midwest IDEAS Investor Conference on Thursday, August 27, 2026, in Chicago.
The presentation is scheduled for 2:40-3:15 PM CT in Presenting Room 2 and will be livestreamed via the conference host's website.
Management will also be available for one-on-one meetings with institutional investors throughout the event.